NVST
Company Description
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.72B | 2.51B | 2.57B | 2.57B | 2.51B | 1.93B | 2.28B | 2.84B | 2.81B | 2.79B |
| Net Income | 47.00M | (1.12B) | (100.20M) | 243.10M | 340.50M | 33.30M | 217.60M | 230.70M | 301.10M | 272.00M |
| EPS | 0.28 | -6.50 | -0.60 | 1.46 | 1.63 | 0.27 | 1.35 | 1.80 | 2.35 | 0.00 |
| Free Cash Flow | 230.40M | 302.70M | 217.50M | 107.00M | 306.90M | 236.20M | 319.70M | 327.90M | 310.20M | 367.90M |
| FCF / Share | 1.37 | 1.76 | 1.30 | 0.66 | 1.90 | 1.48 | 2.35 | 2.12 | 2.01 | 2.38 |
| Operating CF | 275.70M | 336.50M | 275.70M | 182.70M | 361.60M | 283.90M | 397.50M | 400.10M | 359.10M | 417.00M |
| Total Assets | 5.68B | 5.35B | 6.61B | 6.59B | 6.57B | 6.88B | 6.16B | 5.84B | 5.99B | N/A |
| Total Debt | 1.71B | 1.55B | 1.65B | 1.53B | 1.48B | 1.98B | 1.54B | 0 | 0 | N/A |
| Cash & Equiv | 1.21B | 1.07B | 940.00M | 606.90M | 1.07B | 888.90M | 211.20M | 0 | 0 | N/A |
| Book Value | 3.11B | 2.93B | 4.17B | 4.21B | 4.06B | 3.72B | 3.54B | 4.82B | 4.99B | N/A |
| Return on Equity | 0.02 | -0.38 | -0.02 | 0.06 | 0.08 | 0.01 | 0.06 | 0.05 | 0.06 | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 705.50M | 750.60M | 669.90M | 682.10M | 616.90M | 652.90M | 601.00M | 633.10M | 623.60M | 645.60M | 631.30M | 662.40M |
| Net Income | 38.70M | 32.90M | (30.30M) | 26.40M | 18.00M | 1.20M | 8.20M | (1.15B) | 23.60M | (217.40M) | 21.50M | 51.90M |
| EPS | 0.24 | 0.20 | -0.18 | 0.16 | 0.10 | 0.01 | 0.05 | -6.69 | 0.14 | -1.27 | 0.13 | 0.32 |
| Free Cash Flow | (15.80M) | 91.70M | 67.90M | 76.40M | (5.60M) | 123.80M | 63.30M | 86.30M | 29.30M | 93.80M | 77.10M | 61.00M |
| FCF / Share | -0.10 | 0.56 | 0.40 | 0.45 | -0.03 | 0.72 | 0.37 | 0.50 | 0.17 | 0.55 | 0.46 | 0.37 |
| Operating CF | (3.30M) | 108.00M | 78.70M | 88.70M | 300,000 | 132.40M | 70.70M | 93.10M | 40.30M | 102.00M | 95.50M | 75.10M |
| Total Assets | 5.58B | 5.68B | 5.64B | 5.66B | 5.47B | 5.35B | 5.51B | 5.44B | 6.56B | 6.61B | 6.68B | 6.61B |
| Total Debt | 1.59B | 1.71B | 1.60B | 1.60B | 1.56B | 1.55B | 1.57B | 1.64B | 1.65B | 1.65B | 1.64B | 1.53B |
| Cash & Equiv | 1.08B | 1.21B | 1.13B | 1.11B | 1.08B | 1.07B | 991.30M | 1.04B | 948.50M | 940.00M | 824.20M | 651.70M |
| Book Value | 3.08B | 3.11B | 3.09B | 3.14B | 3.04B | 2.93B | 3.07B | 2.98B | 4.14B | 4.17B | 4.29B | 4.31B |
| Return on Equity | 0.01 | 0.01 | -0.01 | 0.01 | 0.01 | 0.00 | 0.00 | -0.39 | 0.01 | -0.05 | 0.01 | 0.01 |